CollPlant Biotechnologies Announces Deal To Acquire Photonic Computing Firm LightSolver For 3,734,476 Upfront Shares Representing 19.7% Of Share Capital, Plus Pre-Funded And Milestone Warrants; Expects Close This Week

CollPlant Announces Publication Of Joint Research Conducted By Its Subsidiary LightSolver Showing Photonic Computing Advantage Over GPUs

Peer-reviewed study published by ACM: LightSolver's LPU architecture demonstrated significantly lower projected time-to-solution, compared to state-of-the-art algorithms running on a GPUREHOVOT, Israel, September

CollPlant Biotechnologies Regains Nasdaq Compliance

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN), today announced the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Listing Rule

CollPlant Biotechnologies shares are trading lower after the company announced a 1-for-10 reverse share split.

CollPlant Biotechnologies Board Approves 1-For-10 Reverse Share Split, Effective September 4

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) ("CollPlant" or the "Company"), today announced that its Board of Directors has approved a one-for-ten reverse share split of the Company's ordinary